| First Author | Golson ML | Year | 2009 |
| Journal | Mech Dev | Volume | 126 |
| Issue | 8-9 | Pages | 687-99 |
| PubMed ID | 19501159 | Mgi Jnum | J:152922 |
| Mgi Id | MGI:4360427 | Doi | 10.1016/j.mod.2009.05.005 |
| Citation | Golson ML, et al. (2009) Jagged1 is a competitive inhibitor of Notch signaling in the embryonic pancreas. Mech Dev 126(8-9):687-99 |
| abstractText | Pancreatic endocrine cells originate from precursors that express the transcription factor Neurogenin3 (Ngn3). Ngn3 expression is repressed by active Notch signaling. Accordingly, mice with Notch signaling pathway mutations display increased Ngn3 expression and endocrine cell lineage allocation. To determine how the Notch ligand Jagged1 (Jag1) functions during pancreas development, we deleted Jag1 in foregut endoderm and examined postnatal and embryonic endocrine cells and precursors. Postnatal Jag1 mutants display increased Ngn3 expression, alpha-cell mass, and endocrine cell percentage, similar to the early embryonic phenotype of Dll1 and Rbpj mutants. However, in sharp contrast to postnatal animals, Jag1-deficient embryos display increased expression of Notch transcriptional targets and decreased Ngn3 expression, resulting in reduced endocrine lineage allocation. Jag1 acts as an inhibitor of Notch signaling during embryonic pancreas development but an activator of Notch signaling postnatally. Expression of the Notch modifier Manic Fringe (Mfng) is limited to endocrine precursors, providing a possible explanation for the inhibition of Notch signaling by Jag1 during mid-gestation embryonic pancreas development. |
